CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题：T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.
T cell subsets in cervical cancer tumor microenvironment: advances and therapeutic opportunities.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
宫颈癌在中国女性中的发病率和死亡率均居第三位。其进展与肿瘤微环境（TME）中免疫细胞之间复杂的相互作用密切相关。作为免疫景观的关键组成部分，不同的T细胞亚群在塑造肿瘤免疫中发挥着多样且动态的作用。本综述全面概述了各种T细胞亚群在宫颈癌TME中的作用，重点关注其分布、功能异质性、动态平衡以及在不同病理亚型和疾病阶段中的变化。我们还重点介绍了T细胞与TME中其他免疫细胞之间复杂的串扰，并讨论了宫颈癌T细胞相关免疫治疗的最新进展，包括免疫检查点抑制剂和HPV靶向疫苗。通过阐明TME中不同T细胞亚群的作用及相关免疫治疗方法，本综述为改善宫颈癌治疗和患者预后提供了潜在治疗靶点和方法的见解。
Cervical cancer is the third most common malignancy among Chinese women in both incidence and mortality. Its progression is closely linked to complex interactions among immune cells within the tumor microenvironment (TME). As key components of the immune landscape, different T cell subsets play diverse and dynamic roles in shaping tumor immunity.
This review provides a comprehensive overview of the roles of various T cell subsets in the TME of cervical cancer, with a focus on their distribution, functional heterogeneity, dynamic balance, and variations across different pathological subtypes and disease stages.
We also highlight the intricate crosstalk between T cells and other immune cells in the TME and discuss recent advances in T cell-related immunotherapies for cervical cancer, including immune checkpoint inhibitors and HPV-targeted vaccines. By elucidating the roles of distinct T cell subsets and relevant immunotherapeutic approaches within the TME, this review provides insights into potential therapeutic targets and approaches for improving cervical cancer treatment and patient outcome.
在 PubMed 查看 → 出版商原文（DOI） 全文 PDF（PMC）· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。
